Aptevo Therapeutics (APVO) EPS (Basic) (2016 - 2022)
Historic EPS (Basic) for Aptevo Therapeutics (APVO) over the last 8 years, with Q4 2022 value amounting to -$0.95.
- Aptevo Therapeutics' EPS (Basic) rose 2519.69% to -$0.95 in Q4 2022 from the same period last year, while for Sep 2023 it was $1.82, marking a year-over-year increase of 103551.03%. This contributed to the annual value of $1.57 for FY2022, which is 12586.49% up from last year.
- Aptevo Therapeutics' EPS (Basic) amounted to -$0.95 in Q4 2022, which was up 2519.69% from $0.03 recorded in Q3 2022.
- In the past 5 years, Aptevo Therapeutics' EPS (Basic) ranged from a high of $1.6 in Q3 2019 and a low of -$7.27 during Q1 2019
- Its 5-year average for EPS (Basic) is -$1.23, with a median of -$0.79 in 2022.
- As far as peak fluctuations go, Aptevo Therapeutics' EPS (Basic) soared by 39078.11% in 2019, and later crashed by 374954.84% in 2021.
- Over the past 5 years, Aptevo Therapeutics' EPS (Basic) (Quarter) stood at -$0.55 in 2018, then soared by 215.87% to $0.64 in 2019, then crashed by 94.54% to $0.03 in 2020, then crashed by 3749.55% to -$1.27 in 2021, then rose by 25.2% to -$0.95 in 2022.
- Its last three reported values are -$0.95 in Q4 2022, $0.03 for Q3 2022, and $0.03 during Q2 2022.